<VariationArchive VariationID="303" VariationName="NM_000552.5(VWF):c.2435del (p.Pro812fs)" VariationType="Deletion" Accession="VCV000000303" Version="29" RecordType="classified" NumberOfSubmissions="14" NumberOfSubmitters="13" DateLastUpdated="2024-07-29" DateCreated="2014-02-25" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15342" VariationID="303">
      <GeneList>
        <Gene Symbol="VWF" FullName="von Willebrand factor" GeneID="7450" HGNC_ID="HGNC:12726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12p13.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="5948877" stop="6124670" display_start="5948877" display_stop="6124670" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6058039" stop="6233835" display_start="6058039" display_stop="6233835" Strand="-" />
          </Location>
          <OMIM>613160</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000552.5(VWF):c.2435del (p.Pro812fs)</Name>
      <CanonicalSPDI>NC_000012.12:6044297:GGGGGG:GGGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12p13.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="6044298" stop="6044298" display_start="6044298" display_stop="6044298" variantLength="1" positionVCF="6044297" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="6153464" stop="6153464" display_start="6153464" display_stop="6153464" variantLength="1" positionVCF="6153463" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>p.P812R fs*31</Name>
      </OtherNameList>
      <ProteinChange>P812fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.6153469del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.6153469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.6044303del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.6044303del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009072.2" sequenceAccession="NG_009072" sequenceVersion="2" change="g.85373del">
            <Expression>NG_009072.2:g.85373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.5" sequenceAccession="NM_000552" sequenceVersion="5" change="c.2435del" MANESelect="true">
            <Expression>NM_000552.5:c.2435del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000543.3" sequenceAccession="NP_000543" sequenceVersion="3" change="p.Pro812fs">
            <Expression>NP_000543.3:p.Pro812fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_587" sequenceAccession="LRG_587">
            <Expression>LRG_587:g.85373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_587t1" sequenceAccession="LRG_587t1">
            <Expression>LRG_587t1:c.2435del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_587p1" sequenceAccession="LRG_587p1" change="p.Pro812fs">
            <Expression>LRG_587p1:p.Pro812fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000552.4" sequenceAccession="NM_000552" sequenceVersion="4" change="c.2435del">
            <Expression>NM_000552.4:c.2435del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114153" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="613160.0021" DB="OMIM" />
        <XRef Type="rs" ID="62643632" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 1302613 Fig. 1 to determine the location of this allele on the current reference sequence. </Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND von Willebrand disease type 3" Accession="RCV000000330" Version="14">
        <ClassifiedConditionList TraitSetID="89">
          <ClassifiedCondition DB="MedGen" ID="C1264041">von Willebrand disease type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-04-12" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND not provided" Accession="RCV000086611" Version="27">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-09" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND Hereditary von Willebrand disease" Accession="RCV000851752" Version="11">
        <ClassifiedConditionList TraitSetID="8941">
          <ClassifiedCondition DB="MedGen" ID="C5703318">Hereditary von Willebrand disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND Abnormal bleeding" Accession="RCV000852083" Version="9">
        <ClassifiedConditionList TraitSetID="47167">
          <ClassifiedCondition DB="MedGen" ID="C1458140">Abnormal bleeding</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND von Willebrand disease type 1" Accession="RCV002264635" Version="9">
        <ClassifiedConditionList TraitSetID="88">
          <ClassifiedCondition DB="MedGen" ID="C1264039">von Willebrand disease type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000552.5(VWF):c.2435del (p.Pro812fs) AND multiple conditions" Accession="RCV002476902" Version="8">
        <ClassifiedConditionList TraitSetID="11728">
          <ClassifiedCondition DB="MedGen" ID="C1264039">von Willebrand disease type 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1264040">von Willebrand disease type 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1264041">von Willebrand disease type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-09" NumberOfSubmissions="14" NumberOfSubmitters="13" DateCreated="2014-02-25" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>von Willebrand, E. A. Hereditar pseudohemofili. Finska Lakar. Hand. 68: 87-112, 1926.</CitationText>
        </Citation>
        <Citation Type="general">
          <CitationText>www.varsome.com</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1301136</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">1302613</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16985174</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17190853</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20851871</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21362127</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22507569</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23834637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29427305</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35343054</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7989040</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8165603</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8367445</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=VWF</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301765</ID>
          <ID Source="BookShelf">NBK7014</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11728" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE I</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 1</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+1/9460" DB="Genetic Alliance" />
                <XRef ID="128106003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17019" />
                <XRef ID="17019" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">autosomal recessive or autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083611</ID>
              </Citation>
              <XRef ID="166078" DB="Orphanet" />
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C1264039" DB="MedGen" />
              <XRef ID="MONDO:0008668" DB="MONDO" />
              <XRef Type="MIM" ID="193400" DB="OMIM" />
            </Trait>
            <Trait ID="9627" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 3</ElementValue>
                <XRef ID="128108002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, recessive form</ElementValue>
                <XRef ID="Von+Willebrand+disease%2C+recessive+form/7419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 Von Willebrand's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 VWD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, severe form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">V WD3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD3</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17025" />
                <XRef ID="17025" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166096" DB="Orphanet" />
              <XRef ID="C1264041" DB="MedGen" />
              <XRef ID="MONDO:0010191" DB="MONDO" />
              <XRef Type="MIM" ID="277480" DB="OMIM" />
            </Trait>
            <Trait ID="15807" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE 2A/IIE</ElementValue>
                <XRef Type="Allelic variant" ID="613160.0039" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE 2CB</ElementValue>
                <XRef Type="Allelic variant" ID="613160.0042" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613160.0040" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE II</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 2</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 2</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+2/9461" DB="Genetic Alliance" />
                <XRef ID="128107007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD2</ElementValue>
                <XRef Type="MIM" ID="613554" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17020" />
                <XRef ID="17020" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166081" DB="Orphanet" />
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C1264040" DB="MedGen" />
              <XRef ID="MONDO:0013304" DB="MONDO" />
              <XRef Type="MIM" ID="613554" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="9627" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 3</ElementValue>
                <XRef ID="128108002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, recessive form</ElementValue>
                <XRef ID="Von+Willebrand+disease%2C+recessive+form/7419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 Von Willebrand's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type 3 VWD</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Von Willebrand disease, severe form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">V WD3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD3</ElementValue>
                <XRef Type="MIM" ID="277480" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17025" />
                <XRef ID="17025" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="166096" DB="Orphanet" />
              <XRef ID="C1264041" DB="MedGen" />
              <XRef ID="MONDO:0010191" DB="MONDO" />
              <XRef Type="MIM" ID="277480" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="88" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9626" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">VON WILLEBRAND DISEASE, TYPE I</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VWD, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">von Willebrand disease type 1</ElementValue>
                <XRef ID="von+Willebrand+disease%2C+type+1/9460" DB="Genetic Alliance" />
                <XRef ID="128106003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VWD1</ElementValue>
                <XRef Type="MIM" ID="193400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17019" />
                <XRef ID="17019" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">autosomal recessive or autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3083611</ID>
              </Citation>
              <XRef ID="166078" DB="Orphanet" />
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C1264039" DB="MedGen" />
              <XRef ID="MONDO:0008668" DB="MONDO" />
              <XRef Type="MIM" ID="193400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47167" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22683" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Abnormal bleeding</ElementValue>
                <XRef ID="HP:0001892" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C1458140" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001892" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004830" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004834" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004849" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004862" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004865" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008183" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8941" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary von Willebrand disease</ElementValue>
                <XRef ID="MONDO:0019565" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Autosomal recessive or Autosomal dominant</Attribute>
                <XRef ID="GTR000502548" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7867" />
                <XRef ID="7867" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Von Willebrand disease (VWD), a congenital bleeding disorder caused by deficient or defective plasma von Willebrand factor (VWF), may only become apparent on hemostatic challenge, and bleeding history may become more apparent with increasing age. Recent guidelines on VWD have recommended taking a VWF level of 30 or 40 IU/dL as a cutoff for those diagnosed with the disorder. Individuals with VWF levels greater than 30 IU/dL and lower than 50 IU/dL can be described as having a risk factor for bleeding. This change in guidelines significantly alters the proportion of individuals with each disease type. Type 1 VWD (~30% of VWD) typically manifests as mild mucocutaneous bleeding. Type 2 VWD accounts for approximately 60% of VWD. Type 2 subtypes include: Type 2A, which usually manifests as mild-to-moderate mucocutaneous bleeding; Type 2B, which typically manifests as mild-to-moderate mucocutaneous bleeding that can include thrombocytopenia that worsens in certain circumstances; Type 2M, which typically manifests as mild-moderate mucocutaneous bleeding; Type 2N, which can manifest as excessive bleeding with surgery and mimics mild hemophilia A. Type 3 VWD (&lt;10% of VWD) manifests with severe mucocutaneous and musculoskeletal bleeding.</Attribute>
                <XRef ID="NBK7014" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301765</ID>
                <ID Source="BookShelf">NBK7014</ID>
              </Citation>
              <XRef ID="903" DB="Orphanet" />
              <XRef ID="C5703318" DB="MedGen" />
              <XRef ID="D014842" DB="MeSH" />
              <XRef ID="MONDO:0019565" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20474" SubmissionDate="2016-08-04" DateLastUpdated="2016-08-22" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613160.0021_VON WILLEBRAND DISEASE, TYPE 3" title="VWF, 1-BP DEL, EX18, C_VON WILLEBRAND DISEASE, TYPE 3" />
        <ClinVarAccession Accession="SCV000020474" DateUpdated="2016-08-22" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1993-12-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Among 24 patients with von Willebrand disease type 3 (277480), Zhang et al. (1992) found that 24 of the 48 chromosomes harbored a 1-bp deletion in a stretch of 6 cytosines at position 2679-2684 in exon 18 of the VWF gene. Nine patients were homozygous and 6 were heterozygous for the mutation. The deletion interrupted the reading frame and resulted in a translational stop codon at position V842 in the amino acid sequence. Translation of the mutant mRNA would yield only a severely truncated mature VWF (48 of 2,050 amino acids) after removal of the propeptide.</Attribute>
              <Citation>
                <ID Source="PubMed">1302613</ID>
              </Citation>
              <XRef DB="OMIM" ID="277480" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Zhang et al. (1993) demonstrated that deletion of 1 cytosine in exon 18 was the mutation in the Aland family (family S) in which the disease was first reported by von Willebrand (1926). They reported studies of descendants of the original family; only heterozygotes were found surviving. The proposita was a 5-year-old girl, who later bled to death during her fourth menstrual period. She had a normal coagulation time, but the bleeding time was prolonged, despite a normal platelet count. All but 1 of her 11 sibs had bleeding symptoms, as did both of her parents, who were third cousins, and many members of her family on both sides. Four of the proband's sisters had died of uncontrolled bleeding in early childhood; 3 died from gastrointestinal bleeding and 1 from bleeding after she bit her tongue in a fall. The predominant symptoms were bleeding from mucous membranes, such as from the nose, the gingivae after tooth extractions, the uterus, and the gastrointestinal tract. In contrast to hemophilia, hemarthroses seemed to be rare. All 5 of the girls who died from uncontrolled bleeding were probably homozygous for the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">8367445</ID>
              </Citation>
              <Citation>
                <CitationText>von Willebrand, E. A. Hereditar pseudohemofili. Finska Lakar. Hand. 68: 87-112, 1926.</CitationText>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Mertes et al. (1993) found that the single cytosine deletion in exon 18 observed in half the alleles of 24 Swedish VWD type 3 patients (Zhang et al., 1992) occurred uncommonly in German patients with type 3 VWD; only 1 out of 24 alleles carried the delta-C mutation. A founder effect might explain the higher frequency in Sweden.</Attribute>
              <Citation>
                <ID Source="PubMed">8165603</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1301136</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <Name>VWF, 1-BP DEL, EX18, C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, EX18, C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613160.0021" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VON WILLEBRAND DISEASE, TYPE 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3096631" SubmissionDate="2021-04-15" DateLastUpdated="2021-05-01" DateCreated="2021-05-01">
        <ClinVarSubmissionID localKey="NM_000552.3:c.2435delC|OMIM:277480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001572662" DateUpdated="2021-05-01" DateCreated="2021-05-01" Type="SCV" Version="1" SubmitterName="Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico" OrgID="507580" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <CitationText>www.varsome.com</CitationText>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277480" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>Type 3 Von Willebrand International Registries Inhibitor Prospective Study (3WINTERS-IPS)</StudyName>
        <StudyDescription>The 3WINTERS-IPS aimed to assess number, types and risk factors for bleeding and the efficacy and safety of plasma-derived and/or recombinant Von Willebrand Factor concentrates used to treat type 3 VWD patients (ClinicalTrials.gov Identifier: NCT02460458)</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB9482148</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4903324" SubmissionDate="2022-05-09" DateLastUpdated="2022-10-01" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="NM_000552.3:c.2435delC|MedGen:C0042974" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV002507238" DateUpdated="2022-10-01" DateCreated="2022-05-16" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK7014</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0042974" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11456530</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5449654" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000552.5:c.2435del|OMIM:193400;277480;613554" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002799677" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.5:c.2435del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193400" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="277480" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613554" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4978984" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-07-09">
        <ClinVarSubmissionID localKey="116719|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002544997" DateUpdated="2024-07-15" DateCreated="2022-07-09" Type="SCV" Version="13" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>VWF: PVS1, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="C" referenceAllele="CG" start="6153463" stop="6153464" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="209862" SubmissionDate="2012-07-31" DateLastUpdated="2014-02-25" DateCreated="2014-02-25">
        <ClinVarSubmissionID localKey="VWF_2435__1" />
        <ClinVarAccession Accession="SCV000118815" DateUpdated="2014-02-25" DateCreated="2014-02-25" Type="SCV" Version="1" SubmitterName="Academic Unit of Haematology, University of Sheffield" OrgID="500250" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.2:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ISTH_VWFDB_2012_1_31</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1668808" SubmissionDate="2018-09-19" DateLastUpdated="2014-02-25" DateCreated="2014-02-25">
        <ClinVarSubmissionID localKey="31715_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000855028" DateUpdated="2014-02-25" DateCreated="2014-02-25" Type="SCV" Version="1" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL ClinVar v180209 classification definitions</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/kvqgb2ud/egl_clinvar_v180209_classification_definitions.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="-" referenceAllele="G" start="6153464" stop="6153464" variantLength="1" />
            <GeneLocation>NM_000552.3:Ex18</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD920917" />
            <XRef DB="dbSNP" ID="62643632" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=VWF</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1769281" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.2435delC_C0042974" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899623" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0758</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">von Willebrand disorder</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0042974" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1769633" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.2435delC_HP:0001892" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000899624" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0392</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0001892" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3869122" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey=":Chr.12_6153463_6153464_CG_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001978298" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, University Medical Center Utrecht" OrgID="274978" OrganizationCategory="laboratory" OrgAbbreviation="GDL-UMCU" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="C" referenceAllele="CG" start="6153463" stop="6153464" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10523642</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3870935" SubmissionDate="2021-10-15" DateLastUpdated="2021-10-16" DateCreated="2021-10-16">
        <ClinVarSubmissionID localKey=":Chr.12_6153463_6153464_CG_C|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001980128" DateUpdated="2021-10-16" DateCreated="2021-10-16" Type="SCV" Version="1" SubmitterName="Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center" OrgID="506497" OrganizationCategory="laboratory" OrgAbbreviation="CGDx-EMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="12" alternateAllele="C" referenceAllele="CG" start="6153463" stop="6153464" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10520787</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4984651" SubmissionDate="2022-06-24" DateLastUpdated="2022-07-18" DateCreated="2022-07-18">
        <ClinVarSubmissionID localKey="NM_000552.3:c.2435delC|OMIM:193400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002546261" DateUpdated="2022-07-18" DateCreated="2022-07-18" Type="SCV" Version="1" SubmitterName="Laboratory of Hematology, Radboud University Medical Center" OrgID="508621" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VWF" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.P812R fs*31</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.3:c.2435delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193400" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>WIN study</StudyName>
        <StudyDescription>The Willebrand in the Netherlands study aims to register and investigate all patients in the Netherlands with moderate and severe von Willebrand Disease to assess clinical presentation, treatment and related complications of treatment.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>WIN study</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1738572" SubmissionDate="2023-12-22" DateLastUpdated="2024-01-06" DateCreated="2014-02-25">
        <ClinVarSubmissionID localKey="S1605|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000888684" DateUpdated="2024-01-06" DateCreated="2014-02-25" Type="SCV" Version="3" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" OrgAbbreviation="Quest Diagnostics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31064749</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8367445</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8165603</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35343054</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23834637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29427305</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21362127</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20851871</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22507569</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7989040</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16985174</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17190853</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1302613</ID>
          </Citation>
          <Comment>This frameshift variant alters the translational reading frame of the VWF mRNA and causes the premature termination of VWF protein synthesis. The frequency of this variant in the general population, 0.00054 (14/26126 chromosomes, http://gnomad.broadinstitute.org), is consistent with pathogenicity. In the published literature, the variant has been described as a common mutation in the Swedish and Finnish populations (PMIDs: 1302613 (1992), 23834637 (2013)), reported in heterozygous patients with vWD type I (PMIDs: 16985174 (2007), 17190853 (2007)), and in homozygous or compound heterozygous patients with vWD type III (PMIDs: 23834637 (2013), 29427305 (2018), 35343054 (2022)). Based on the available information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Quest Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.4:c.2435del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108248</SubmissionName>
          <SubmissionName>SUB4481696</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8981532" SubmissionDate="2024-03-26" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="NM_000552.4:c.2435del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004803198" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="Institute of Immunology and Genetics Kaiserslautern" OrgID="508836" OrganizationCategory="laboratory" OrgAbbreviation="IIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG Criteria: PVS1, PM2, PP5; Variant was found in heterozygous state</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001977" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002597" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000552.4:c.2435del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="193400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14339567</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5449654" TraitType="Disease" MappingType="XRef" MappingValue="193400" MappingRef="OMIM">
        <MedGen CUI="C1264039" Name="von Willebrand disease type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8981532" TraitType="Disease" MappingType="XRef" MappingValue="193400" MappingRef="OMIM">
        <MedGen CUI="C1264039" Name="von Willebrand disease type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769281" TraitType="Disease" MappingType="Name" MappingValue="von Willebrand disorder" MappingRef="Preferred">
        <MedGen CUI="C0042974" Name="von Willebrand disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3096631" TraitType="Disease" MappingType="XRef" MappingValue="277480" MappingRef="OMIM">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4978984" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3870935" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1738572" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1668808" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8981532" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002597" MappingRef="HP">
        <MedGen CUI="C0241657" Name="Abnormality of the vasculature" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4903324" TraitType="Disease" MappingType="XRef" MappingValue="C0042974" MappingRef="MedGen">
        <MedGen CUI="C0042974" Name="von Willebrand disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449654" TraitType="Disease" MappingType="XRef" MappingValue="613554" MappingRef="OMIM">
        <MedGen CUI="C1264040" Name="von Willebrand disease type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3869122" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="20474" TraitType="Disease" MappingType="Name" MappingValue="VON WILLEBRAND DISEASE, TYPE 3" MappingRef="Preferred">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449654" TraitType="Disease" MappingType="XRef" MappingValue="277480" MappingRef="OMIM">
        <MedGen CUI="C1264041" Name="von Willebrand disease type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8981532" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001977" MappingRef="HP">
        <MedGen CUI="C4025731" Name="Abnormal thrombosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769633" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001892" MappingRef="HP">
        <MedGen CUI="C1458140" Name="Abnormal bleeding" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="209862" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4984651" TraitType="Disease" MappingType="XRef" MappingValue="193400" MappingRef="OMIM">
        <MedGen CUI="C1264039" Name="von Willebrand disease type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

